Quick Answer
IceCure Medical Ltd. reported Research And Development Expense of $7.43 million for the year ending 2025.
- IceCure Medical Ltd. showed an increase of +4.7% in Research And Development Expense from 2024 to 2025.
- This data is from IceCure Medical Ltd.'s annual report (Form 10-K), filed with the SEC on March 17, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), IceCure Medical Ltd.'s Research And Development Expense has grown by 95.1%.
- Historical annual values: Fiscal year 2025: $7.43 million | Fiscal year 2024: $7.10 million | Fiscal year 2023: $8.27 million | Fiscal year 2022: $9.12 million | Fiscal year 2021: $5.88 million | Fiscal year 2020: $3.81 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: